As one of seven companies picked for the pilot, the integrated development and manufacturing organization says earlier regulatory engagement will cut commercialization risk.
The investment will modernize the company’s API manufacturing site to support growing demand for U.S.-based CDMO services and increasingly complex drug substances.
The mobile maintenance platform will be deployed across the company’s global manufacturing network following a successful implementation at its production site in Spain.
UV is a comprehensive solution for chloramine reduction and can work synergistically with activated carbon, helping to reduce waste, lower operating costs, and minimize the amount of carbon needed over time.
